Skip to main content
Log in

Comparative serum protein binding of anthracycline derivatives

  • SHORT COMMUNICATION
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

 The binding of doxorubicin, iododoxorubicin, daunorubicin, epirubicin, pirarubicin, zorubicin, aclarubicin, and mitoxantrone to 600 μM human serum albumin and 50 μM alpha1-acid glycoprotein was studied by ultrafiltration at 37°C and pH 7.4. Anthracycline concentrations (total and free) were determined by high-performance liquid chromatography (HPLC) with fluorometric detection. Binding to albumin (600 μM) varied from 61% (daunorubicin) to 94% (iododoxorubicin). The binding to alpha1-acid glycoprotein (50 μM) was more variable, ranging from 31% (epirubicin) to 64% (zorubicin), and was essentially related to the hydrophobicity of the derivatives. Simulations showed that the total serum binding varied over a broad range from 71% (doxorubicin) to 96% (iododoxorubicin).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 8 October 1995 / Accepted: 20 March 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chassany, O., Urien, S., Claudepierre, P. et al. Comparative serum protein binding of anthracycline derivatives. Cancer Chemother Pharmacol 38, 571–573 (1996). https://doi.org/10.1007/s002800050529

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002800050529

Navigation